MedTrace Logo

Deep Brain Stimulation Therapy and Intestinal Microbiota

NCT04855344 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-04-22

No results posted yet for this study

Summary

This study aims to observe the changes of intestinal microbiota after deep brain stimulation (DBS) therapy for Parkinson's disease, and explore the role of intestinal microbiota in the neuroprotective effect of DBS.

Conditions

  • Deep Brain Stimulation
  • Gastrointestinal Microbiome

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Cunming Liu · The First Affiliated Hospital with Nanjing Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04855344 on ClinicalTrials.gov